Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients

Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients

Background: Programmed cell death 1 ligand-1 (PD-L1) is an immune checkpoint molecule that acts to protect cancer cells from immune surveillance and is considered as a prognostic biomarker in several cancers, but the prognostic value of PD-L1 in bone and soft tissue sarcomas remains inconclusive. In...

Full description

Bibliographic Details
Main Authors: Feng Wang, Tao Yu, Chengbin Ma, Hongmou Yuan, Haifei Zhang, Zhiyu Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
programmed cell death 1 ligand-1
sarcoma
meta-analysis
prognosis
overall survival
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00749/full

Similar Items

Similar Items